L2 Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026L2 Asset Management, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $55.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$55.1M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 27,740 | $9.8M |
| GILDGILEAD SCIENCES, INC. | 66,161 | $9.2M |
| UTHRUNITED THERAPEUTICS Corp | 14,091 | $8.4M |
| RPRXRoyalty Pharma plc | 147,082 | $7.1M |
| CAHCardinal Health Inc. | 24,705 | $5.2M |
| INCYIncyte Corp. | 42,145 | $4.0M |
| ABBVAbbVie Inc. | 12,615 | $2.7M |
| MRKMerck & Co., Inc. | 14,105 | $1.7M |
| IQVIQVIA Holdings Inc. | 9,600 | $1.6M |
| BMYBRISTOL MYERS SQUIBB CO | 25,140 | $1.5M |
| JNJJOHNSON & JOHNSON | 3,088 | $755K |
| CORCencora Inc. | 2,301 | $723K |
| MCKMcKesson Corporation | 655 | $567K |
| PMPhilip Morris International Inc | 3,161 | $523K |
| GMOptec International, Inc. | 4,881 | $364K |
| ZTSZoetis Inc. | 2,384 | $282K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 748 | $247K |
| IDXXIDEXX LABORATORIES INC /DE | 427 | $240K |
| EBSEmergent BioSolutions Inc. | 25,782 | $214K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.